Rhie, B.-H.; Karapurkar, J.K.; Kim, H.-Y.; Woo, S.H.; Gowda, D.A.A.; Kim, D.H.; Choi, M.J.; Park, Y.J.; Matam, V.; Hong, Y.;
et al. A Multikinase Inhibitor AX-0085 Blocks FGFR1 Activation to Overcomes Osimertinib Resistance in Non-Small Cell Lung Cancer. Biomedicines 2026, 14, 66.
https://doi.org/10.3390/biomedicines14010066
AMA Style
Rhie B-H, Karapurkar JK, Kim H-Y, Woo SH, Gowda DAA, Kim DH, Choi MJ, Park YJ, Matam V, Hong Y,
et al. A Multikinase Inhibitor AX-0085 Blocks FGFR1 Activation to Overcomes Osimertinib Resistance in Non-Small Cell Lung Cancer. Biomedicines. 2026; 14(1):66.
https://doi.org/10.3390/biomedicines14010066
Chicago/Turabian Style
Rhie, Byung-Ho, Janardhan Keshav Karapurkar, Hyun-Yi Kim, Sang Hyeon Woo, D. A. Ayush Gowda, Dong Ha Kim, Myeong Jun Choi, Young Jun Park, Viswanathaiah Matam, Yoonki Hong,
and et al. 2026. "A Multikinase Inhibitor AX-0085 Blocks FGFR1 Activation to Overcomes Osimertinib Resistance in Non-Small Cell Lung Cancer" Biomedicines 14, no. 1: 66.
https://doi.org/10.3390/biomedicines14010066
APA Style
Rhie, B.-H., Karapurkar, J. K., Kim, H.-Y., Woo, S. H., Gowda, D. A. A., Kim, D. H., Choi, M. J., Park, Y. J., Matam, V., Hong, Y., Hong, S.-H., Ramakrishna, S., & Kim, K.-S.
(2026). A Multikinase Inhibitor AX-0085 Blocks FGFR1 Activation to Overcomes Osimertinib Resistance in Non-Small Cell Lung Cancer. Biomedicines, 14(1), 66.
https://doi.org/10.3390/biomedicines14010066
